Molecu Light In Action
The MolecuLight i:X device enables clinicians to see and target bacteria in skin and chronic wounds in real-time. (Photo: Courtesy of MolecuLight Inc.)

UHN-invented MolecuLight Inc. achieved a major regulatory milestone permitting expansion into the United States market.

The U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the groundbreaking wound fluorescence imaging device, the MolecuLight i:X.

Developed by Dr. Ralph DaCosta, Molecular Imaging Scientist at Princess Margaret Cancer Centre and Techna Institute, UHN, the device digitally captures and documents fluorescence information from wounds and surrounding tissue using still images and videos in real-time.

"The MolecuLight i:X platform is a significant advancement in the management of chronic wounds, that is already revolutionizing wound care practice in Canada and Europe," says Dr. DaCosta, Founder, Chief Scientific Officer and Director of MolecuLight Inc.

Chronic wounds resulting from hospital-acquired infections, an epidemic of diabetes and the increasingly complex health issues of an aging population, are a growing burden on patients, healthcare providers and healthcare systems.

"Thousands of patients to date have already experienced a change in their assessment and treatment by clinicians who feel empowered by the wound fluorescence images they are seeing. As reported in multi-centered published clinical studies, clinicians used the images to inform their wound management practices in real-time, in particular, for guided wound sampling, cleaning and debridement," Dr. DaCosta says.

"We're very excited that U.S. clinicians will soon have the same access to this device as their peers in Canada and Europe.''

Fire Marshals at TG evacuate inpatient transplant unit

Fire Marshals
Thanks to great teamwork between the staff on 7A and fire marshals at Toronto General Hospital successfully completed its annual fire drill with 66 minutes to spare. (Photo: UHN)

The transplant inpatient unit on 7A at Toronto General Hospital (TG) exceeded all standards during UHN's annual fire drill with Toronto Fire Services last month.

Fire Marshal Perry Ross says the six staff in the unit who were involved in the drill had 75 minutes to evacuate 11 mock patients, but they were able to complete the drill in just nine minutes.

With exceptional teamwork and guidance from the TG fire marshals, the staff on the unit safely evacuated the mock patients to an area on the floor where they would be safe from a potential fire.

"We test out emergency preparedness in the event of a real fire situation – the ability for us to evacuate the floor in a timely manner is extremely important," Perry says.

Volunteers from Volunteer Resources simulated patients in the unit during the drill, which Toronto Fire Services must oversee at every hospital once a year.

Back to Top